Loading...
Immage Biotherapeutics Corp.
IMMG•PNK
Financial ServicesFinancial - Conglomerates
$0.00
$0.00(0.00%)
Immage Biotherapeutics Corp. (IMMG) Stock Overview
Explore Immage Biotherapeutics Corp.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for IMMGStats details for IMMG are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for IMMGAnalyst Recommendations details for IMMG are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.
CEO
Mr. Zhi Cong Mou
Employees
3
Founded
2022